Fumaric Acid

Fumaric Acid

SCHEMBL1936098

CCCN1CCC(CC(=O)N(CC)c2ccc(Cl)c(Cl)c2)CC1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.38
CHRM3 known ✓ P20309 1/20 0.38
KCNH2 known ✓ Q12809 1/20 0.38
CCR5 P51681 12/20 0.42
KDM2B Q8NHM5 1/20 0.40
TACR2 P21452 1/20 0.40
TACR1 P25103 1/20 0.38
OPRM1 P35372 1/20 0.38
CCR2 P41597 2/20 0.38
SIGMAR1 Q99720 1/20 0.38
CACNA1I Q9P0X4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2395364 0.94 CCR5 (0.46) CCR5KDM2BTACR2OPRM1SIGMAR1
Fumaric Acid SCHEMBL1936589 0.92 HRH3 (0.41) CCR5CCR2CHRM2CHRM3
Fumaric Acid SCHEMBL1935942 0.86 TP53 (0.40) CCR5OPRM1CCR2KCNH2
SCHEMBL2398884 0.85 HRH3 (0.45) CCR5CHRM2CHRM3
Fumaric Acid SCHEMBL1936089 0.85 CCR5 (0.39) CCR5OPRM1
SCHEMBL2395603 0.84 CCR5 (0.41) CCR5OPRM1CHRM3
Hydrochloric Acid SCHEMBL2396854 0.83 OPRM1 (0.41) CCR5OPRM1CHRM3
Fumaric Acid SCHEMBL2394308 0.82 PGR (0.35) CCR5OPRM1
Fumaric Acid SCHEMBL1936311 0.82 DRD2 (0.35) OPRM1
Fumaric Acid SCHEMBL1936259 0.81 HRH1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212997-A1 PIPERIDINE-4-ACETAMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NEUROSEARCH A/S (DK) 2011-09-01 US disclosed
EP-2331505-A2 PIPERIDINE-4-ACETAMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NeuroSearch A/S (DK) 2011-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212997-A1 PIPERIDINE-4-ACETAMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS SLC18A2, SLC6A2, SLC18A3 CHRM2 441/4885CHRM3 780/4885KCNH2 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.